Peter Lundberg has joined Solexa (Hayward, California) as vice president and chief technical officer. He will be responsible for all R&D activities at the company's California location. Lundberg most recently was vice president, DNA platforms R&D, at the Applied Biosystems unit of Applera. In other appointments, Dr. Tony Smith, who had served as the chief technology officer of Solexa until its recent business combination with Lynx Therapeutics, has been promoted to vice president and chief scientific officer. He will continue to be responsible for all R&D activities in the UK and will now be the senior manager for the company in the UK. Dr. Mary Schramke, who headed Lynx product development and served as Lynx's interim CEO prior to the combination of the firms, has taken the post of vice president and general manager of genomic services. Solexa is developing DNA sequencing systems for the comprehensive and economical analysis of whole genomes, to be used by customers in a wide range of applications.

• WellPoint (Indianapolis) reported the retirement of two members of its executive leadership team, David Frick, executive vice president and chief legal and administrative officer, and Rebecca Kapustay, president and CEO of Blue Cross Blue Shield of Wisconsin and a corporate executive vice president. The company also named Angela Braly executive vice president, general counsel and chief public affairs officer, and Stuart Campbell president of Blue Cross Blue Shield of Missouri and Wisconsin. Braly currently is president of Blue Cross Blue Shield of Missouri, and Campbell is senior vice president of strategic planning and management process. Kapustay's retirement and the two appointments are effective April 1. Frick will retire July 1. WellPoint was created in November 2004 from the merger of Anthem and WellPoint Health Networks. Blue Cross Blue Shield of Wisconsin and Blue Cross Blue Shield of Missouri are operating units of WellPoint.